Invezz

Why Palantir stock is trading near 52 week low?

Why Palantir stock is trading near 52 week low?
Ananthu C U
25 Jun 2026, 22:06 PM

powered by

Invezz
PLTR buy

Buy Palantir (PLTR) for a rebound from a technical/valuation washout. The stock is near a 52-week low, has broken key supports (~$127 and the weekly support), and is trading far below the 50-day (~$137) and 200-day (~$159) moving averages—conditions that often trigger sharp mean-reversion rallies once selling pressure pauses. The thesis is that enterprise AI demand remains intact and the market is over-penalizing multiple risk (trailing P/E >100) after a broad software re-rating. Wolfe’s renewed coverage and high upside to consensus targets ($189.87) supports a “bad tape, good business” setup.

Key Risk: A sustained growth slowdown that forces earnings downgrades, not just a valuation reset.

ChapsVision/France risk sell

Sell Palantir (PLTR) exposure tied to France government intelligence contracts by shorting PLTR outright (or reducing long exposure) because the France plan to phase out Palantir tools is a direct hit to a visible international growth leg. If the domestic alternative (ChapsVision) gains traction, it can pressure renewals, reduce contract visibility, and worsen sentiment just as the stock is already breaking technical levels. This is a catalyst-driven thesis: policy-driven contract substitution can take time to reverse, keeping the multiple compressed.

Key Risk: France’s phase-out is delayed or limited, and Palantir wins replacement work/renewals that offset the loss.

  • Palantir stock fell for a seventh straight day to a 12-month low.
  • Shares are down 48% from their record high and 31% this month.
  • Analysts still see 67% upside despite valuation and contract risks.

Shares of Palantir Technologies extended their recent slide on Thursday, falling for a seventh consecutive trading session and putting the stock on track for its lowest close in more than a year.

Palantir shares dropped 5.8% to $106.88 during trading.

If losses hold, the stock will close at its lowest level since April 24, 2025, according to Dow Jones Market Data.

The decline marks a difficult stretch for investors. The stock has fallen nearly 20% since last Tuesday and is down 31% this month.

If the losses persist through month-end, Palantir would record its worst monthly percentage decline since February 2021, when shares dropped 32%.

The stock is now down 48% from its record closing high of $207.18 reached on Nov. 3, 2025.

So far in 2026, Palantir shares have declined 39%, underperforming broader markets as investors reassess growth-oriented technology stocks.

For comparison, the S&P 500 has gained 7.8% this year, while the Nasdaq Composite is up 9%.

Technical breakdown and valuation concerns weigh on shares

The recent selloff has also led to a significant deterioration in Palantir's technical picture.

On Monday, the stock fell below a key support level around $127 that had held since February, a move that suggested further downside risk. Shares are now trading roughly 15% below that threshold.

Thursday's decline also pushed the stock below another important support area on its weekly chart, a level it had maintained over the past 12 months.

Palantir is also moving further away from major moving averages. The stock's 50-day moving average is currently around $137, while its 200-day moving average stands near $159.

The company is also facing pressure from a broader re-rating across richly valued software companies.

Investors have increasingly rotated away from high-multiple technology stocks amid rising interest-rate expectations and weakness in semiconductor and hardware shares.

With its trailing price-to-earnings ratio comfortably above 100 times earnings, Palantir has been particularly vulnerable to this shift in market sentiment.

European contract concerns add to investor worries

Beyond valuation concerns, investors are also monitoring geopolitical and contract risks that could affect Palantir's international growth strategy.

In France, the country's domestic intelligence agency has announced plans to phase out Palantir's data tools in favor of a domestic alternative developed by ChapsVision.

Meanwhile, in the United Kingdom, renewed political pressure has emerged over Palantir's Federated Data Platform contract with the National Health Service.

Parliamentary committees have urged the government to consider exercising a February 2027 break clause that could terminate the agreement.

Despite the stock's sharp decline, some analysts remain optimistic about the company's long-term prospects.

Wolfe Research recently resumed coverage of Palantir with an upgraded rating.

“Today, we see PLTR as the most applied enterprise AI software company, with the largest and fastest growth rates in the industry,” Wolfe Research analyst Alex Zukin wrote.

“We love the business, and if growth trends closer to our upside scenario we could find ourselves looking at an entry point too good to ignore,” Zukin added.

According to FactSet data, Palantir carries an average Overweight rating and a price target of $189.87, implying approximately 67% upside from current trading levels.

Of the 33 firms surveyed by FactSet, 17 rate the stock Buy, three rate it Overweight, 11 recommend Hold, and two have Sell ratings.